Supplier
Arthritis and Rheumatism Associates PC
Arthritis and Rheumatism Associates PC was paid $2.79M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 26% of everything it billed.
33Billing provider infoARTHRITIS AND RHEUMATISM ASSOCIATES PC
ROCKVILLE, MD 20850
ROCKVILLE, MD 20850
33aNPI1447259866assigned 07/18/2005
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$2.79M
24GClaims60,340
24DCodes billed54
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in Maryland
Rank by total paid#1 of 9
Median peer was paid$554K
This provider vs. median5.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,079 | $257K | |
| 2019 | 9,918 | $305K | |
| 2020 | 5,696 | $289K | |
| 2021 | 7,287 | $376K | |
| 2022 | 9,880 | $460K | |
| 2023 | 8,884 | $622K | |
| 2024incomplete | 8,596 | $478K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 26% | 5,333 | 5,030 | $725K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 20% | 3,369 | 2,936 | $570K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 18% | 1,682 | 1,511 | $512K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 9,267 | 8,540 | $287K |
| 96401 | 6.0% | 886 | 873 | $168K | |
| 96415 | 3.7% | 722 | 606 | $103K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.2% | 1,462 | 1,373 | $88K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 826 | 764 | $58K |
| 86140 | 2.0% | 5,440 | 5,093 | $56K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 5,859 | 5,498 | $36K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 1.2% | 1,243 | 1,187 | $34K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 1,422 | 1,311 | $24K |
42 more codes
| 85652 | <1% | 5,282 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,175 | $18K |
| 20611 | <1% | 1,083 | $16K | |
| 81001 | <1% | 172 | $14K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 448 | $9K |
| 20610 | <1% | 207 | $6K | |
| 86160 | <1% | 324 | $6K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,741 | $5K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 959 | $4K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 306 | $3K |
| 84550 | <1% | 92 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,216 | $2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | <1% | 109 | $2K |
| 73562 | <1% | 30 | $2K | |
| 73130 | <1% | 41 | $2K | |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | <1% | 27 | $1K |
| 86225 | <1% | 161 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 469 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 907 | $1K |
| J0897 | Injection, denosumab, 1 mg | <1% | 1,355 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $978.59 |
| 90653 | <1% | 26 | $843.93 | |
| 87081 | <1% | 67 | $785.65 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 129 | $761.71 |
| G0008 | Administration of influenza virus vaccine | <1% | 131 | $651.34 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 34 | $532.31 |
| J3262 | Injection, tocilizumab, 1 mg | <1% | 524 | $420.12 |
| 89060 | <1% | 65 | $343.45 | |
| 86200 | <1% | 117 | $342.90 | |
| 89051 | <1% | 79 | $319.19 | |
| 99442 | <1% | 13 | $290.78 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $201.84 |
| 86431 | <1% | 102 | $167.70 | |
| 84165 | <1% | 39 | $20.16 | |
| 86255 | 0% | 116 | $0.00 | |
| 97162 | 0% | 13 | $0.00 | |
| 97164 | 0% | 28 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 77 | $0.00 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 0% | 85 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 29 | $0.00 |
| 82570 | 0% | 12 | $0.00 | |
| 86038 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKJOLHEDE, JOSHUA (HR GENERALIST)